Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells

Blood

Volumn 90, Issue 4, 1997, Pages 1545-1551

  Shibakura, Misako ^b   Koyama, Takatoshi ^a   Saito, Takako ^b   Shudo, Koichi ^b   Miyasaka, Nobuyuki ^b   Kamiyama, Ryuichi ^b   Hirosawa, Shinsaku ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DI TERT BUTYL 4' CHALCONECARBOXYLIC ACID; LE 540; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN; RETINOID DERIVATIVE; RO 25 7386; RO 415253; TAMIBAROTENE; THROMBOMODULIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTIC LEUKEMIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; TRANSCRIPTION REGULATION;

EID: 0030761728     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1545.1545_1545_1551     Document Type: Article

References (31)

1. Chambon P: A decade of molecular biology of retinoic acid receptors. FASEB J 10:940, 1996
2. Fisher GJ, Talwar HS, Xiao J-H, Datta SC, Reddy AP, Gaub M-P, Rochette-Egly C, Chambon P, Voorhees JJ: Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J Biol Chem 269:20629, 1994
3. Dawson MI, Elstner E, Kizaki M, Chen D-L, Pakkala S, Kerner B, Koeffler HP: Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood 84:446, 1994
4. Koyama T, Hirosawa S, Kawamata N, Tohda S, Aoki N: All-trans retinoic acid (ATRA) upregulates thrombomodulin and downregulates tissue factor expression in acute promyelocytic leukemia cells: Distinct expression of thrombomodulin and tissue factor in human leukemic cells. Blood 84:3001, 1994
5. Saito T, Koyama T, Nagata K, Kamiyama R, Hirosawa S: Anticoagulant effects of retinoic acids on leukemia cells. Blood 87:657, 1996
6. Shudo K, Kagechika H: Structual evolution of retinoids. Adv Drug Res 24:81,1993
7. Umemiya H, Kawachi E, Kagechika H, Fukasawa H, Hashimoto Y, Shudo K: Synergists for retinoid in cellular differentiation of human promyelocytic leukemia cells HL-60. Chem Pharm Bull 43:1827, 1995
8. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W, Klaus M: A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 89:7129, 1992
9. Kooistra T, Lansink M, Arts J, Sitter T, Toet K: Involvement of retinoic acid receptor α in the stimulation of tissue-type plasminogen activator gene expression in human endothelial cells. Eur J Biochem 232:425, 1995
10. Koyama T, Parkinson JF, Aoki N, Bang NU, Müller-Berghaus G, Preissner KT: Relationship between post-translational glycosylation and anticoagulant function of secretable, recombinant mutants of human thrombomodulin. Br J Haematol 78:515, 1991
11. Fiore MM, Neuenschwander PF, Morrissey JH: An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates. Blood 80:3127, 1992
12. Lanotte M, Martin-Thouvenin V, Najiman S, Balerini P, Valensi F, Berger R: NB-4, a maturation inducible cell line with t(15:17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
13. Dermime S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG, Gambacorti-Passerini C: Occurrence of resistance to retinoic acid in The acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RARα protein. Blood 82:1573, 1993
14. Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, Kuriyama R, Matsuzawa K, Hasegawa R, Aoki N: Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 87:343, 1994
15. Bartha K, Brisson C, Archipoff G, de la Salle C, Lanza F, Cazenave J-P, Beretz A: Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanism. J Biol Chem 268:421, 1993
16. Pötgens AJG, Lubsen NH, van Altena G, Shoenmakers JGG, Ruiter DJ, de Waal RMW: Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay. Thromb Haemost 71:208, 1994
17. Rickles FR, Hair GA, Zeff RA, Lee E, Bona RD: Tissue factor expression in human leukocytes and tumor cells. Thromb Haemost 74:391, 1995
18. Forman BM, Umesono K, Chen J, Evans RM: Unique response pathways are established by allosteric interactions among nuclear receptors. Cell 81:541, 1995
19. Dittman WA, Nelson SC, Greer PK, Horton ET, Palomba ML McCachren SS: Characterization of thrombomodulin expression in response to retinoic acid and identification of a retinoic acid response element in the human thrombomodulin gene. J Biol Chem 269:16925, 1994
20. Schüle R, Rangarajan P, Yang N, Kliewer S, Ransone LJ, Bolado J, Verma IM, Evans RM: Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci USA 88:6092, 1991
21. Nagpal S, Athanikar J, Chandraratna RAS: Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α. J Biol Chem 270:923, 1995
22. Largman C, Detmer K, Corral JC, Hack FM, Lawrence J: Expression of retinoic acid receptor alpha mRNA in human leukemia cells. Blood 74:99, 1989
23. de The H, Marchio A, Tiollais P, Dejean A: Differential expression and ligand regulation of the retinoic acid receptor α and β genes. EMBO J 8:429, 1989
24. Chen JD, Evans RM: A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454, 1995
25. Lala DS, Mukherjee R, Schulman FG, Canan Koch SS, Dardashti LJ, Nadzan AM, Croston GE, Evans RM, Heyman RA: Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature 383:450, 1996
26. Pan L, Eckhoff C, Brinckerhoff CE: Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J Cell Biol 57:575, 1995
27. Degos L, Dombret H, Chomienne C, Daniel M-T, Micléa J-M, Chastang C, Castaigne S, Fenaux P: All-trans-retinoic acid as a differentiation agent in the treatment of acute promyelocytic leukemia. Blood 85:2643, 1995
28. Takeshita A, Shibata Y, Shinjo K, Yanagi M, Tobita T, Ohnishi K, Miyawaki S, Shudo K, Ohno R: Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinoid, Am8O. Ann Intern Med 124:893, 1996
29. Barstad RM, Hamers MJAG, Stephens RW, Sakariassen S: Retinoic acid reduces induction of monocyte tissue factor and tissue factor/factor Vila-dependent arterial thrombus formation. Blood 86:212, 1995
30. Falanga A, lacoviello L, Evangelista V, Belotti D, Consonni R, D'Orazio A, Robba L, Doanati MB, Barbui T: Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. Blood 86:1072, 1995
31. Ishii H, Horie S, Kizaki K, Kazama M: Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood 80:2556, 1992